Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity
- 2 June 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (11), 2752-2757
- https://doi.org/10.1016/j.bmcl.2005.03.114
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesityExpert Opinion on Investigational Drugs, 2004
- Recent developments in the discovery of melanin-concentrating hormone antagonists: novel antiobesity agentsExpert Opinion on Therapeutic Patents, 2004
- 5-HT2C receptor agonists as potential drugs for the treatment of obesity.Current Topics in Medicinal Chemistry, 2003
- Targeted Disruption of the Melanin-Concentrating Hormone Receptor-1 Results in Hyperphagia and Resistance to Diet-Induced ObesityEndocrinology, 2002
- Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolismProceedings of the National Academy of Sciences, 2002
- Body Fat Content Can Be Predicted In Vivo in Mice Using a Modified Dual-Energy X-Ray Absorptiometry TechniqueJournal of Nutrition, 2001
- Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistanceJCI Insight, 2001
- Melanin-concentrating Hormone Receptor: An Orphan Receptor Fits the KeyTrends in Endocrinology & Metabolism, 2000
- Central nervous system control of food intakeNature, 2000
- Mice lacking melanin-concentrating hormone are hypophagic and leanNature, 1998